Benjamin F. Edwards & Company Inc. Has $6.73 Million Stake in The Clorox Company (NYSE:CLX)

Benjamin F. Edwards & Company Inc. increased its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 211.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 47,169 shares of the company's stock after purchasing an additional 32,017 shares during the quarter. Benjamin F. Edwards & Company Inc.'s holdings in Clorox were worth $6,725,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in CLX. Fortitude Family Office LLC acquired a new stake in shares of Clorox during the 4th quarter worth approximately $29,000. Tyler Stone Wealth Management lifted its stake in Clorox by 64.5% in the third quarter. Tyler Stone Wealth Management now owns 255 shares of the company's stock valued at $33,000 after buying an additional 100 shares during the last quarter. Hartford Financial Management Inc. boosted its holdings in shares of Clorox by 57.1% during the fourth quarter. Hartford Financial Management Inc. now owns 256 shares of the company's stock valued at $37,000 after acquiring an additional 93 shares during the period. Valley National Advisers Inc. boosted its holdings in shares of Clorox by 458.3% during the fourth quarter. Valley National Advisers Inc. now owns 268 shares of the company's stock valued at $38,000 after acquiring an additional 220 shares during the period. Finally, BKM Wealth Management LLC bought a new position in shares of Clorox during the fourth quarter worth about $41,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Price Performance

NYSE CLX traded down $1.44 on Friday, reaching $138.23. The company's stock had a trading volume of 2,036,238 shares, compared to its average volume of 1,340,454. The firm's 50 day moving average is $148.45 and its two-hundred day moving average is $143.17. The stock has a market cap of $17.17 billion, a PE ratio of 71.62, a PEG ratio of 2.18 and a beta of 0.44. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.57 and a current ratio of 0.90. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $176.24.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating the consensus estimate of $1.33 by $0.38. The business had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business's quarterly revenue was down 5.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.51 earnings per share. As a group, sell-side analysts predict that The Clorox Company will post 5.8 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be issued a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.47%. The ex-dividend date is Tuesday, April 23rd. Clorox's payout ratio is 248.71%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Citigroup cut their price objective on shares of Clorox from $155.00 to $150.00 and set a "neutral" rating on the stock in a research report on Wednesday. UBS Group reduced their price objective on Clorox from $164.00 to $159.00 and set a "neutral" rating for the company in a research report on Wednesday. Jefferies Financial Group raised Clorox from an "underperform" rating to a "hold" rating and set a $145.00 price objective for the company in a report on Tuesday, March 26th. Wells Fargo & Company cut their target price on Clorox from $140.00 to $135.00 and set an "underweight" rating on the stock in a research note on Thursday. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on Clorox from $155.00 to $151.00 and set a "hold" rating for the company in a research report on Wednesday, April 17th. Four equities research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $146.43.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.